Certolizumab
- Generic Name
- Certolizumab
- Brand Names
- -
- Drug Type
- -
- Chemical Formula
- -
- CAS Number
- -
- Unique Ingredient Identifier
- -
- Indication
本品与甲氨蝶呤（MTX）合用，用于治疗对改善病情的抗风湿药（DMARDs）（包括MTX）疗效不佳的中重度活动性类风湿关节炎（RA）成年患者。
- Associated Conditions
- -
- Associated Therapies
- -
Gastrointestinal Diseases Therapeutics Market to Grow by USD 18.5 Billion from 2024-2028
The Global Gastrointestinal Diseases Therapeutics Market is projected to grow by USD 18.5 billion from 2024-2028, driven by increasing disease incidence and nutritional therapies. Key players include Abbott Laboratories, AbbVie Inc., AstraZeneca Plc, and others. High treatment costs pose a challenge.
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath